Cargando…
Enhanced tonic GABA(A) inhibition in typical absence epilepsy
The cellular mechanisms underlying typical absence seizures, which characterize various idiopathic generalized epilepsies, are not fully understood, but impaired GABAergic inhibition remains an attractive hypothesis. In contrast, we show here that extrasynaptic GABA(A) receptor–dependent ‘tonic’ inh...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824149/ https://www.ncbi.nlm.nih.gov/pubmed/19966779 http://dx.doi.org/10.1038/nm.2058 |
_version_ | 1782177700057710592 |
---|---|
author | Cope, David W. Di Giovanni, Giuseppe Fyson, Sarah J. Orbán, Gergely Errington, Adam C. Lőrincz, Magor L. Gould, Timothy M. Carter, David A. Crunelli, Vincenzo |
author_facet | Cope, David W. Di Giovanni, Giuseppe Fyson, Sarah J. Orbán, Gergely Errington, Adam C. Lőrincz, Magor L. Gould, Timothy M. Carter, David A. Crunelli, Vincenzo |
author_sort | Cope, David W. |
collection | PubMed |
description | The cellular mechanisms underlying typical absence seizures, which characterize various idiopathic generalized epilepsies, are not fully understood, but impaired GABAergic inhibition remains an attractive hypothesis. In contrast, we show here that extrasynaptic GABA(A) receptor–dependent ‘tonic’ inhibition is increased in thalamocortical neurons from diverse genetic and pharmacological models of absence seizures. Increased tonic inhibition is due to compromised GABA uptake by the GABA transporter GAT–1 in the genetic models tested, and GAT–1 is critical in governing seizure genesis. Extrasynaptic GABA(A) receptors are a requirement for seizures in two of the best characterized models of absence epilepsy, and the selective activation of thalamic extrasynaptic GABA(A) receptors is sufficient to elicit both electrographic and behavioural correlates of seizures in normal animals. These results identify an apparently common cellular pathology in typical absence seizures that may have epileptogenic significance, and highlight novel therapeutic targets for the treatment of absence epilepsy. |
format | Text |
id | pubmed-2824149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
record_format | MEDLINE/PubMed |
spelling | pubmed-28241492010-06-01 Enhanced tonic GABA(A) inhibition in typical absence epilepsy Cope, David W. Di Giovanni, Giuseppe Fyson, Sarah J. Orbán, Gergely Errington, Adam C. Lőrincz, Magor L. Gould, Timothy M. Carter, David A. Crunelli, Vincenzo Nat Med Article The cellular mechanisms underlying typical absence seizures, which characterize various idiopathic generalized epilepsies, are not fully understood, but impaired GABAergic inhibition remains an attractive hypothesis. In contrast, we show here that extrasynaptic GABA(A) receptor–dependent ‘tonic’ inhibition is increased in thalamocortical neurons from diverse genetic and pharmacological models of absence seizures. Increased tonic inhibition is due to compromised GABA uptake by the GABA transporter GAT–1 in the genetic models tested, and GAT–1 is critical in governing seizure genesis. Extrasynaptic GABA(A) receptors are a requirement for seizures in two of the best characterized models of absence epilepsy, and the selective activation of thalamic extrasynaptic GABA(A) receptors is sufficient to elicit both electrographic and behavioural correlates of seizures in normal animals. These results identify an apparently common cellular pathology in typical absence seizures that may have epileptogenic significance, and highlight novel therapeutic targets for the treatment of absence epilepsy. 2009-11-22 2009-12 /pmc/articles/PMC2824149/ /pubmed/19966779 http://dx.doi.org/10.1038/nm.2058 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Cope, David W. Di Giovanni, Giuseppe Fyson, Sarah J. Orbán, Gergely Errington, Adam C. Lőrincz, Magor L. Gould, Timothy M. Carter, David A. Crunelli, Vincenzo Enhanced tonic GABA(A) inhibition in typical absence epilepsy |
title | Enhanced tonic GABA(A) inhibition in typical absence epilepsy |
title_full | Enhanced tonic GABA(A) inhibition in typical absence epilepsy |
title_fullStr | Enhanced tonic GABA(A) inhibition in typical absence epilepsy |
title_full_unstemmed | Enhanced tonic GABA(A) inhibition in typical absence epilepsy |
title_short | Enhanced tonic GABA(A) inhibition in typical absence epilepsy |
title_sort | enhanced tonic gaba(a) inhibition in typical absence epilepsy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824149/ https://www.ncbi.nlm.nih.gov/pubmed/19966779 http://dx.doi.org/10.1038/nm.2058 |
work_keys_str_mv | AT copedavidw enhancedtonicgabaainhibitionintypicalabsenceepilepsy AT digiovannigiuseppe enhancedtonicgabaainhibitionintypicalabsenceepilepsy AT fysonsarahj enhancedtonicgabaainhibitionintypicalabsenceepilepsy AT orbangergely enhancedtonicgabaainhibitionintypicalabsenceepilepsy AT erringtonadamc enhancedtonicgabaainhibitionintypicalabsenceepilepsy AT lorinczmagorl enhancedtonicgabaainhibitionintypicalabsenceepilepsy AT gouldtimothym enhancedtonicgabaainhibitionintypicalabsenceepilepsy AT carterdavida enhancedtonicgabaainhibitionintypicalabsenceepilepsy AT crunellivincenzo enhancedtonicgabaainhibitionintypicalabsenceepilepsy |